Trial Profile
Maintenance of benefit after 8-week and 52-week treatment with atomoxetine hydrochloride in adolescents with ADHD
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Apr 2010
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 01 Dec 2009 Results published in the Journal of Child and Adolescent Psychiatry.
- 13 Dec 2006 Status change
- 28 Jul 2006 Status change